Transmedics Group Inc’s recently made public that its Director EDWARD BASILE acquired Company’s shares for reported $0.52 million on Aug 04 ’25. In the deal valued at $125.51 per share,4,143 shares were bought.
Then, Ranganath Anil P. sold 686 shares, generating $95,903 in total proceeds. Upon selling the shares at $139.80, the insider now owns 13,955 shares.
Before that, Basile Edward M sold 5,000 shares. Transmedics Group Inc shares valued at $632,250 were divested by the Director at a price of $126.45 per share. As a result of the transaction, Basile Edward M now holds 2,866 shares, worth roughly $0.37 million.
JP Morgan downgraded its Transmedics Group Inc [TMDX] rating to a Neutral from a an Overweight in a research note published on December 17, 2024; the price target was decreased to $75 from $116. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in late November from “a Buy” to “a Hold”. Oppenheimer also remained covering TMDX and reiterated its “an Outperform” recommendation on October 29, 2024. Needham maintained its rating on October 29, 2024. It rated TMDX as “a Buy”.
Price Performance Review of TMDX
On Monday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock jump 6.59% to $128.5. Over the last five days, the stock has gained 22.10%. Transmedics Group Inc shares have fallen nearly -9.67% since the year began. Nevertheless, the stocks have risen 106.09% over the past one year.
How much short interest is there in Transmedics Group Inc?
A steep rise in short interest was recorded in Transmedics Group Inc stocks on 2025-07-15, growing by 0.13 million shares to a total of 8.0 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 7.86 million shares. There was a rise of 1.68%, which implies that there is a positive sentiment for the stock.
